TNFRSF11B and breast cancer: Our data adds to a rapidly emerging body of evidence that a BRCA mutation may be associated with aberrancies in the OPG/RANK- signaling axis and may represent a potential therapeutic target for the non-surgical prevention of breast cancer in this high-risk population.